CLINICAL SUPPLY MANAGEMENT ARTICLES
Post-Acquisition Clinical Supply Chain Risk: Continuity Before Consolidation
Acquisitions can disrupt clinical trial supply when knowledge, decision rights, inventory data, and supplier responsibilities fail to transfer. Learn how to protect continuity.
CLINICAL SUPPLY MANAGEMENT RESOURCES
-
This white paper addresses the common challenges faced by biopharma organizations with regards to supply chain management and offers insight into solutions by leveraging the RTSM/IRT.
-
Pharmacy-led DTP models cut site burden, improve inventory control, and expand trial access. Learn how to optimize your decentralized trial supply chain for compliance and patient outcomes.
-
The pharmaceutical industry is full of acronyms. Gain insight into the evolution of the acronyms, the technology and the terminology, specifically for RTSM (Randomization and Trial Supply Management).
-
Learn how this biopharmaceutical research sponsor was able to centralize and digitalize the processes involved in clinical supply production through distribution using GxP Inventory.
-
Gain insight into the changing comparator sourcing landscape, focusing specifically on the instrumental role the Bolar exemption plays in the shift away from dependence on innovators for clinical supplies.
-
Rising trial complexity demands agile supply built on integrated operations, solid planning, and fast issue resolution. Lean teams gain from partners providing flexibility, control, and global reach.
-
When selecting a supply chain partner, due diligence is critical. This article highlights questions you should be asking to ensure you are selecting the right supply chain partner for your clinical trial needs.